Antidepressant drugs and heart electrical field

Physiological Research

Volumn 47, Issue 4, 1998, Pages 297-300

  Slavicek J ^a   Paclt, I ^a   Hamplova J ^a   Kittnar, O ^a   Trefny Z ^a   Horacek B M ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antidepressants; Cardiac depolarization; ECG body surface mapping; Lithium; Repolarization; SSRI Citalopram; Tricyclic

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOSULEPIN; LITHIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RESPONSE; ELECTROCARDIOGRAM; FEMALE; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CONTRACTILE FORCE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINUS TACHYCARDIA; VECTORCARDIOGRAPHY;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARDIOVASCULAR DISEASES; CITALOPRAM; DOTHIEPIN; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART; HEART RATE; HUMANS; LITHIUM; MALE; MENTAL DISORDERS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TACHYCARDIA;

EID: 0031692271     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ACOSTA D., RAMOS K.: Cardiotoxicity of tricyclic antidepressants in primary cultures of rat myocardial cells. J. Toxicol. Environ. Health 14: 137-143, 1984.
2. BIGGER J.T. Jr., GIARDINA E.G.V., PEREL J.M., KANTOR S.J., GLASSMAN A.H.: Cardiac antiarrhythmic effect of imipramine hydrochloride. N. Engl. J. Med. 296: 206-208, 1977.
3. BIGGER J.T. Jr.: Implications of the cardiac arrhythmia suppression trial for antiarrhythmic drug treatment. Am. J. Cardiol. 65: 3D-10D, 1990.
4. BRADLEY L., DOGGRELL S.A.: Effects of amitriptyline and mianserin on noradrenergic transmission in the rat isolated right ventricle. J. Auton. Pharmacol. 4: 287-285, 1983.
5. CARMELIET E.E: Influence of lithium ions on the transmembrane potential and cation content of cardiac cells. J. Gen. Physiol. 47: 501-530, 1964.
6. ENEMARK B.O.: The importance of ECG monitoring in antidepressant treatment. Nord. J. Psychiat. 47 (Suppl.): 57-65, 1993.
7. GLASSMAN A.H., ROOSE S.P., GIARDINA E.G.V., BIGGER J.T. Jr.: Cardiovascular effects of tricyclic antidepressants. In: Psychopharmacology: The Third Generation of Progress, MELTZER H. Y. (ed.), New York, Raven Press, 1987, pp. 1437-1442.
8. GLASSMAN A.H., ROOSE S. P., RIVELLI S.K., PREUD'HOMME X.A.: Cardiovascular effects of antidepressant drugs. Nord. J. Psychiat. 47 (Suppl.): 41-47, 1993.
9. JANVIER N.C., BOYETT M.R.: The role of Na-Ca exchange current in the cardiac action potential. Cardiovasc. Res. 32: 69-84, 1996.
10. KITTNAR O., SLAVÍČEK J., VÁVROVÁ M., BARNA M., DOHNALOVA A., MÁLKOVÁ A., ASCHERMANN M., HUMHAL J., HRADEC J., KRAL J.: Repolarization patterns of body surface potential maps (BSPM) in coronary artery disease. Physiol. Res. 42:123-130, 1993.
11. MELEDIN V.Y., ANTYUFIEV V.F., MASHANOV G.I.: Effect of amitriptyline on the contractility of a cardiac muscle. Dobutrex as a positive inotropic agent. Anesthesiol. Reanimatol. 1: 76-79, 1997.
12. MINAROVIČ I., ZAHRADNÍK I., ZAHRADNÍKOVÁ A.: Effect of antidepressants on Ca-current in rat ventricular myocytes. J. Mol. Cell. Cardiol. 27: A130, 1995.
13. MITCHELL J.E., MACKENZIE T.B: Cardiac effects of lithium therapy in man: a review. J. Clin. Psychiat. 43: 47-51, 1982.
14. MITCHELL L.B., HUBLEY-KOZEY C.L., SMITH E.R., VYSE D.G., DUFF H.J., GILLIS A.M., HORÁČEK B.M.: Electrocardiographic body surface mapping in patients with ventricular tachycardia: assessment of utility in the identification of effective pharmacologic therapy. Circulation 86: 383-393, 1992.
15. MLADOŠEVIČOVÁ B., HULÍN I., POGADY J., MARTISOVA D., PETRÁŠOVÁ H., HUBKA P.: Signal-averaged ECG in patients with antidepressant therapy. Int. J. Cardiol. 54: 27-31, 1996.
16. PACLT I., SLAVÍČEK J., KITTNAR O., DOHNALOVÁ A.: Electrocardiological changes during the treatment with antidepressants in man. Homeostasis 36: 223-227, 1995.
17. RAWLINGS D., FOZZARD H.A.: Electrophysiological effects of imipramine on cardiac Purkinje fibres. Am. J. Cardiol. 41: 387-390, 1978.
18. ROSENQVIST M., BERGFELD L., AILI H., MATHE AA.: Sinus node dysfunction during long-term lithium treatment. Br. Heart J. 70: 371-375, 1993.
19. SLAVÍČEK J., PACLT I., KITTNAR O., DOHNALOVÁ A.: Some electrocardiographic side effects of antidepressant drugs. Cor Vasa 37: 212-216, 1995.
20. STOJAN M., BOUDÍK F., ANGEL J.: The methodology of clinical analysis of electric heart field. Physiol. Res. 42: 85-90, 1993.
21. TACCARDI B.: Distribution of heart potentials on the thoracic surface of normal human subjects. Circ. Res. 12: 341-352, 1963.
22. TACCARDI B.: Body surface mapping and cardiac electric sources. A historical survey. J. Electrocardiol. 23 (Suppl.): 150-154, 1990.
23. VAUGHAN-WILLIAMS E.M.: Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial. J. Clin. Pharmacol. 31: 123-135, 1991.
24. WELD F.M., BIGGER J.T.: Effects of imipramine hydrochloride on electrophysiological properties of sheep cardiac Purkinje fibers. Am. J. Cardiol. 41: 386-392, 1978.
25. WESTER H.A., SIEGERS C.P.: Cardiovascular effects of mianserin and amitriptyline in healthy volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 18: 513-517, 1980.